Urinalysis Market – Global Industry Size, Share and Growth, 2023

Urine sample test stripThe global urinalysis market is witnessing considerable growth due to increasing prevalence of diabetes, increasing geriatric population, increasing prevalence of kidney diseases and growing urinary tract infections (UTI). Moreover, increasing healthcare expenditure increases the affordability of patients leading to the increased sales of urinalysis products, supporting the growth of the market. Based on product, the consumables segment is expected to grow at a faster rate during the forecast period, compared to instrument segment. The increasing adoption of dipsticks across the globe owing to their ease of use, cheaper price and easy availability over the counter (OTC) is driving the growth of this segment.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/urinalysis-market/report-sample

Increase in diabetic cases leads to increased sales of urinalysis dipsticks, disposables and devices across the globe. For instance, according to the World Health Organization (WHO) the global diabetes prevalence has increased from 4.7% to 8.5% from 1980 to 2014, respectively. As per International Diabetes Federation (IDF), Western Pacific (WP) region consists of maximum diabetes cases; its prevalence was 138 million cases in 2014, which is expected to reach 202 million in 2035. Similarly, according to IDF, the prevalence of diabetes in South-East Asia (SEA) is expected to increase from 75 million in 2014 to 123 million in 2035.

Urinalysis is a screening test which includes visual, chemical and microscopic examinations used to detect the presence of substances such as crystals or casts, cells, and cell fragments in the urine. It is widely adopted across the globe to detect liver problems, UTI, diabetes and pregnancy in patients.

Explore Report at: https://www.psmarketresearch.com/market-analysis/urinalysis-market

The key players operating in the global urinalysis market are F. Hoffmann-LA Roche AG, Danaher Corporation, Siemens AG, Sysmex Corporation, Bio-Rad Laboratories, Inc., Mindray Medical International Limited, Acon Laboratories, Inc., Arkray, Inc. and Urit Medical Electronic Group Co., Ltd.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Advertisements

Top Key Players Operating In the Healthcare IT Integration Market and Growth Strategies

Healthcare IT Integration MarketHealthcare IT integration is a consortium of IT and healthcare sector and involves the application of latest IT solutions to monitor people’s health, perform secured exchange of their electronic data and provide economical healthcare solutions. The application of IT in other domains has presented positive outcomes and the same is expected in terms of healthcare. The global healthcare IT integration market is estimated to witness a considerable growth during the forecast period. The major factors that will accelerate the growth of the healthcare IT integration market are high healthcare costs, government initiatives to curb this rising cost and the growing demand to incorporate IT in the healthcare domain. However, the cost of incorporation is expensive and needs to monitored for the growth in the global market.

Download free Report Sample at@ https://www.psmarketresearch.com/market-analysis/healthcare-it-integration-market/report-sample

The healthcare IT integration market has been categorized on the basis of product and services, and application. The products in healthcare IT integration market include interface/integration engines, media integration solutions, medical device integration software, and other integration tools. Based on the services provided, the market is segmented into implementation services, support and maintenance services, and training services. In the services segment, support and maintenance services hold the largest healthcare IT Integration market share and is expected to hold its position during the forecast period 2013-2023.

The players in the global market are focusing to launch products with technological advancements which is causing rapid growth of the market. Another key factor that drives the growth of the healthcare IT integration market is the integration of healthcare industry with information technology and application of IoT (Internet of Things) to curb the overall healthcare cost. The government organizations have been providing their support and taking initiatives for the growth of the healthcare integration market size. The exchange of patient’s clinical data among hospitals and their partners, provides solutions for complex interoperability challenges and further supports the market growth.

Pre-Purchase Inquiry at@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=healthcare-it-integration-market

Other key players in the global healthcare IT integration market are Quality Systems Inc., Allscripts Healthcare Solutions, Inc., Orion Health, Oracle Corporation, Qualcomm Life, Inc., IBM Corporation, Corepoint Health LLC, GE Healthcare, Siemens Health, Epic Systems Corporation, Summit Healthcare Services, Inc.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Medical Claims Management Solutions Market – Global Industry Analysis, Size and Growth till 2023

Medical Claims Management Solutions MarketA medical claim is a detailed invoice that a health care provider sends to the health insurer, exactly showing the services that have been rendered by the providers to the patient. Medical claims management involves multiple administrative and customer service layers that include review, investigation, adjustment, remittance or denial of a claim. Improved focus on quality healthcare services and adoption of cloud technology related services are contributing to the growth of the medical claims management solutions market. Medical claims management solutions generally aim at attaining complete automation of processing of claims, faster access to customer information without negotiating on the security of private medical information. However, insurance claim payers and providers need to be convinced about the need for these solutions and also the benefits of investing in them despite their sizeable cost. Automation helps in reducing costs associated with processing of claims, utilizing a single platform for all data sources, workflows for routing claims for review and approval processes, increasing the uniformity of payments, and timely payment of claims.

Get Free Report Sample at@ https://www.psmarketresearch.com/market-analysis/medical-claims-management-solutions-market/report-sample

The medical claims management solutions market is driven by factors such as advent of new and innovative treatments & technologies, improved focus on quality healthcare services and adoption of cloud-based technology related services. Moreover, increase in the number of patients covered under medical insurance and expensive care required for chronic diseases have supported the growth of the medical claims management solutions industry. Also, the increase in aging population, initiatives taken by government in order to improve insurance coverage among citizens and rise in occurrence of chronic diseases affect the market thus, driving the growth of medical claims management solutions market. According to the World Health Organization (WHO), contribution of chronic diseases is expected to rise to 73% of all deaths and 60% of the global burden of disease by 2020. Moreover, 79% of the deaths attributed to these diseases occur in developing countries. Additionally, as per United Nations Department of Economic and Social Affairs (UN-DESA) report on the global aging population, the population of people aged 60 years or above is growing at a high rate. The number of people aged 60 years or over is projected to grow by 56.0 % globally, i.e. from 901 million in 2015 to 1.4 billion by 2030, and it is projected to more than double its size from 2015, to reach 2.1 billion by 2050.

North America and Europe together hold a significant share of the medical claims management solutions market, due to the increased use of software and hardware for processing claims and presence of top insurance companies in these regions. The North American medical claims management solutions market size accounted for the largest share of the global market in 2016, and is expected to maintain its position during the forecast period (2017-2023). This growth is attributable to the presence of well-established healthcare system in the region, rise in prevalence of chronic diseases, increase in insurance coverage, and technological advancements in the medical claims management solutions market.

Pre-Purchase Inquiry at@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=medical-claims-management-solutions-market

The major players in the medical claims management solutions market include IBM Corporation, Cerner Corporation, Oracle Corporation, Avaya Inc., Genpact Limited, Cognizant Technology Solutions Corporation, Accenture PLC, Allscripts Healthcare Solutions, Inc., Athenahealth Inc., Aspect Software Inc., and Infor Inc.

Browse Other Related Reports: http://bit.ly/2o38qHM

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

New Growth Opportunities lie in the Organic Based Scar Treatment Products

Scar Treatment IndustryThe global scar treatment market is likely to grow significantly during the forecast period, due to increasing prevalence of skin diseases such as psoriasis, eczema, vitiligo and photoaging of skin, which is increasing due to excessive exposure to pollution and ultraviolet radiation. This further results in sunburns, reduced skin elasticity, and hair loss. Skin diseases are also caused by various other factors, such as excessive alcohol consumption, environmental pollution, and consumption of tobacco. These conditions without proper treatment on time, can lead to the formation of scars. Various other skin problems such as, acne, burns, post-surgical marks, and stretch marks due to pregnancy or changes in body weight can also lead to scar formation. However, side effects of scar treatment products and therapies and high cost associated with scar treatment are some of the key factors restraining the growth of global scar treatment market.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/scar-treatment-market/report-sample

North America was the largest market for scar treatment in 2016 and is expected to contribute 40.5 % by 2023. This dominant position of the region is primarily attributable to high disposable income, which further increases spending on personal care products. Moreover, the increasing appearance consciousness among the population in the region has also led to a rise in the adoption of technologically advanced scar treatment products.

There has been increasing popularity of various organic scar treatment products available in the market, thereby leading to additional opportunity being created for the manufacturers of scar treatment products. The different organic products available in the market are rosehip oil, olive oil, lemon extracts, apple cider vinegar, essential oils, and organic scar treatment creams. These products are non-toxic, inexpensive, and promote natural healing of scars. These products are cost effective, easy to use, and have very few side effects. Some of the organic scar treatment products offered by various companies are blemish gel, virgin cold pressed rose hip oil, peppermint, tea tree, eucalyptus face wash, and manuka face cream. These organic scar treatment products with minimum side-effects are expected to create considerable revenue generation opportunities for the scar treatment products manufacturers.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=scar-treatment-market

Some of the other key players in the global scar treatment market are Smith & Nephew Plc, Syneron Medical Ltd., Mölnlycke Health Care AB, Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Beijing Toplaser Technology Company Ltd., Merz GMBH & Co KGAA, Valeant Pharmaceuticals International Inc., Pacific World Corporation, Avita Medical Ltd. Enaltus LLC, Sonoma Pharmaceuticals Inc., CCA Industries Inc., Scarguard Labs LLC, Quantum Health, Hologic Inc.

Cleanroom Technology Market Scenario, Leading Players, Segments Analysis and Growth Drivers to 2023

Cleanroom Technology at P&S Market ResearchCleanroom technology market is forecasted to attain $5 billion value by 2023, growing at a CAGR of 5.7% during 2017-2023. The growth in the market is likely to be led by increased demand for certified products, rising healthcare expenditure, technological advancements in cleanrooms, rising demand from pharmaceutical, biotech, and medical devices industries, and favorable healthcare regulations.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/cleanroom-technology-market/report-sample

Cleanroom technology products are mainly used in the pharmaceutical, biotechnology, and medical devices industries, with some of the other users being hospitals, research laboratories and academic institutions. Pharmaceutical industry contributed the largest share to the cleanroom technology market and its growth is mainly attributable to the presence of a large number of biopharmaceutical companies, which further leads to a high production of finished pharmaceutical products, worldwide.

North America generated the maximum revenue in the cleanroom technology market, mainly attributable to the increased adoption of cleanroom technology products due to their benefits. HEPA filters are efficient in removing microbes from the air that is expelled out from the industries. According to an article published in 2008 by the U.S. Food and Drug Association (USFDA), HEPA filters are mainly used by the companies that are involved in the manufacturing, processing, and packaging of frozen foods. These filters have an efficiency of 99.97% to 99.99%, which prevents contamination from harmful microorganisms such as L.monocytogenes, a bacterium responsible for spoiling food.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=cleanroom-technology-market

Some of the other key players operating in the cleanroom technology market include M+W Group GmbH, E.I. du Pont de Nemours and Company, Kimberly-Clark Corporation, Taikisha Ltd., Azbil Corporation, Illinois Tool Works Inc., Ardmac Ltd., and Alpiq Group.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Microscopic Polyangiitis Therapeutics Pipeline 2018 – Patent, Designation and Collaboration

Microscopic Polyangiitis TherapeuticsMicroscopic polyangiitis is an inflammatory disorder that leads to the damage of organs such as kidneys, lungs, skin, joints, and nerves. The disease can be symptomatized by weight loss, inflammation of the kidneys, skin lesions, fever, nerve damage, skin rash, muscle and joint pain, loss of sensation, seizures, abdominal pain, and cough. However, the cause of microscopic polyangiitis is unknown, but it is thought that the overactive immune system causes the inflammation in the tissues and blood vessels. The Chiba University is in the process of developing glucocorticoids for the treatment of microscopic polyangiitis. ChemoCentryx, Inc. is also in the process of developing avacopan (CCX168) as a C5a receptor antagonist for the treatment of microscopic polyangiitis. Some of the companies having the pipeline of microscopic polyangiitis include Amgen plc, ChemoCentryx, Inc., and others.

Explore Report at: https://www.psmarketresearch.com/market-analysis/microscopic-polyangiitis-therapeutics-pipeline-analysis

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/microscopic-polyangiitis-therapeutics-pipeline-analysis/report-sample

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Multiple System Atrophy Therapeutics – Pipeline Analysis, Clinical Trials, Designation and Collaboration

Multiple System Atrophy Therapeutics Pipeline Analysis 2018

Multiple System Atrophy TherapeuticsMultiple system atrophy is a type of neurodegenerative disorder that affects movement of the body and the autonomic nervous system which leads to loss of function and death of the nerve cells in spinal cord and brain. Multiple system atrophy can be symptomatized by erectile dysfunction, bladder control and fainting spells. Due to motor nervous system impairment, difficulties with speech and gait, along with tremor and rigidity occurs. However, the cause of the disease is still unknown, but it has been observed that the accumulation of alpha synuclein causes the degradation of nerve cells in the brain and spinal cord. The University Hospital, Toulouse is in the process of developing L-Threo DOPS as a synthetic precursor of norepinephrine, for the treatment of multiple system atrophy. The Vanderbilt University is in the process of developing BQ-123 as an endothelin receptor (ETA) antagonist for the treatment of multiple system atrophy. Some of the universities and companies having the pipeline of multiple system atrophy include Vanderbilt University, New York University School of Medicine, CORESTEM, Inc. and others.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/multiple-system-atrophy-therapeutics-pipeline-analysis/report-sample

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=multiple-system-atrophy-therapeutics-pipeline-analysis

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

 

Immune Checkpoint Inhibitors Market – Pipeline Analysis, Size, Share and Demand, 2023

Immune Checkpoint Inhibitors MarketThe global immune checkpoint inhibitors market is expected to witness significant growth as these are proven to be more effective therapy in shrinking tumor in higher proportion of patients, as compared to other immunotherapies. Immune checkpoint inhibitors are applicable to a wider range of tumor types such as advanced or metastatic non-small cell lung cancer, renal cancer and melanoma. These inhibitors lower the rate of severe toxicities and immune-mediated side-effects. These are also convenient to administer and yield a good response rate of any single-agent immunotherapy.

Get Report Sample at: https://www.psmarketresearch.com/market-analysis/immune-checkpoint-inhibitors-market/report-sample

The pharmaceutical companies are actively involved in the research and development of drug for immune checkpoint inhibitors. The pipeline of immune checkpoint inhibitors is rich with more than 50 drugs. In November 2016, Bristol-Myers Squibb Company and Infinity Pharmaceuticals collaborated to check the efficacy of combination of Opdivo (a PD-1 inhibitor monoclonal antibody) and IPI-549 (a phosphoinositide-3-kinase gamma inhibitor) in patients with advanced solid tumors.

Immune checkpoints comprised of cytotoxic T-lymphocyte antigen 4 (CTLA-4) inhibitors and PD-1 and PD-L1 inhibitors. CTLA-4 drug are molecules used to regulate, stimulate or inactivate the immune cells. PD-1 is found on the surface of cancer cells and it is used by tumors to evade the immune system; therefore, PD-1 inhibitor blocks PD-1 action and enables the body to attack and kill cancer cells. PD-L1 is a transmembrane protein of 40kDa that helps in suppressing the immune system during tissue allograft, pregnancy, autoimmune disease, hepatitis and other diseases.

Immune checkpoint inhibitors are showing good efficacy with PD-1 and PD-L1 inhibitors and CTLA-4 inhibitors. Yervoy, an anti-CTLA-4 product of Bristol-Myers Squibb Company got approved in the year 2011. The increased use of combination therapy of PD-1 and PD-L1 inhibitors represent a new signal of immunotherapeutics, which is expected to alter the standard of care for cancer across the globe. However, the development of effective immunotherapy presents some challenges due to complex pathophysiology of cancer and difficulty in managing treatment related toxic effects, which is expected to hamper the growth of the global market to some extent.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=immune-checkpoint-inhibitors-market

Some of the key players operating in the global market are Merck & Co., Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Pfizer Inc., F. Hoffmann-La Roche AG, Novartis AG, Regeneron Pharmaceuticals, Inc., Ono Pharmaceutical Co., Ltd., and TG Therapeutics, Inc.

Chronic Pain Treatment Market – Pipeline Analysis, Size and Growth, 2023

Chronic Pain TreatmentThe global chronic pain treatment market is expected to witness considerable growth due to current unmet medical need of chronic pain, technological advancement in pain therapeutic and diagnostic test, and increasing number of chronic diseases such as cancer, arthritis, and diabetes mellitus. In addition, increasing geriatric population and increasing disposable income are supporting the growth of the global chronic pain market. The pharmaceutical companies are actively involved in the research and development of drugs for chronic pain. Camurus is developing CAM2038, long-acting subcutaneous buprenorphine injections for the treatment of opioid dependence and pain.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/chronic-pain-treatment-market/report-sample

Chronic pain is defined as the pain that persists for more than 3 months or longer. It adversely affects patient’s quality of life that may limit a person’s movements, which can interfere with daily activities. This difficulty in carrying out work related or other activities can lead to disability and despair. Chronic pain persists and sends pain signals to the nervous system for weeks, months or even years. It also affects the peripheral and central nervous system called neuropathy that result from damage to or pathological changes of the peripheral or central nervous system. The actual cause of chronic pain is unknown. Some people feel chronic pain without having any past injury or evidence of body damage.

A large number of pharmaceutical companies are working for the research and development of drugs for chronic pain treatment. The pipeline of the chronic pain treatment drug candidate is rich. However, certain factors such as high treatment cost through branded drugs and decreased patient compliance are the key factors for impeding the growth of the global market during the forecast period.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=chronic-pain-treatment-market

Some of the key players operating in the global chronic pain market are Pfizer, Inc., Cara Therapeutics, Inc., Endo Pharmaceuticals Inc., Teikoku Pharma USA, Inc., Allergan plc, Purdue Pharma L.P., Mallinckrodt plc, AstraZencea plc, Jazz Pharmaceuticals plc, and Nektar Therapeutics.

Personalized Medicine Market – Global Industry Analysis, Size and Growth, 2023

Personalized Medicine MarketThe global personalized medicine market is expected to witness significant growth due rapid advancement in diagnostic techniques, population heterogeneity across the globe, increasing awareness about the benefits of genetic makeup based drugs, and improving quality of disease diagnosis. The key vendors in the global personalized medicine market are focusing on oncology, infectious disease and cardiovascular targeted treatment and diagnostics.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/personalized-medicine-market/report-sample

The pharmaceutical companies and biotechnology companies are actively involved in the research and development of personalized medicine. Different companies are developing and manufacturing biologics, such as blood products, vaccines, nutritional products, and gene therapies, to improve the quality of patient life. In December 2014, U.S. Food and Drug Administration (FDA) approved Lynparza, a poly (ADP-ribose) polymerase inhibitor as monotherapy in patients with deleterious or suspected deleterious germline breast cancer mutated advanced ovarian cancer, who have been treated with three or more prior lines of chemotherapy. Also in the same year, the organization approved the VIMIZIM, an enzyme replacement therapy for the treatment of patients with Morquio A syndrome.

National Cancer Institute, a part of the U.S. National Institutes of Health (NIH) defined personalized medicine as a form of medicine that uses information about a person’s genes, proteins and environment to prevent, diagnose and treat disease. In cancer, personalized medicine uses specific information about a person’s tumor to help diagnose, plan treatment, find out how well treatment is working, or make a prognosis. Personalized medicine uses targeted therapies to treat specific types of cancer cells, such as HER2-positive breast cancer cells, and to develop tumor marker for the diagnosis of cancer.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=personalized-medicine-market

Some of the key players operating in the global personalized medicine market are GE Healthcare, Illumina Inc., Quest Diagnostics Incorporated, Abbott, Affymetrix, Inc., Bayer AG, F. Hoffmann-La Roche AG, AstraZeneca PLC, Pfizer Inc., Valeant Pharmaceuticals International, Inc., and Vertex Pharmaceuticals Incorporated.